Please use this identifier to cite or link to this item:
http://mfuir.mfu.ac.th:80/xmlui/handle/123456789/992
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Karn Matangkha | en_US |
dc.contributor.author | Jarasphol Rintra | en_US |
dc.contributor.author | Vichit Punyahotara | en_US |
dc.contributor.author | Phakkharawat Sittiprapaporn | en_US |
dc.date.accessioned | 2025-07-25T05:47:26Z | - |
dc.date.available | 2025-07-25T05:47:26Z | - |
dc.date.issued | 2025-07-25 | - |
dc.identifier.citation | GMS Medicine Journal. Vol.5, No.3 (September - December 2025) : p.149-158 | en_US |
dc.identifier.issn | 2730-3446 | - |
dc.identifier.uri | http://mfuir.mfu.ac.th:80/xmlui/handle/123456789/992 | - |
dc.description | บทความ (Article) | en_US |
dc.description.abstract | Background: Long COVID is a condition where individuals continue to experience persistent symptoms after recovering from the initial COVID-19 infection. Vitamin D is one of the vital minerals for maintaining normal health conditions and may be associated with the psychiatric symptoms of long COVID. Objective: To examine the prevalence of psychiatric symptoms in long COVID-19 patients in association with vitamin D levels. Materials and Methods: This study employed a cross-sectional descriptive design, focusing on 170 patients who had previously contracted the COVID-19 virus at Foresta Clinic. The data collected included demographic data, vitamin D levels, and psychiatric symptoms in long COVID (anxiety, depression, and sleep disorders). Result: The study results indicated a female-to-male ratio of 1.1:1 among the patients, with a mean age of 45.87 ± 8.65 years. Additionally, 62.4% had received three doses of the COVID-19 vaccine. The median blood vitamin D level was 22.96 ng/mL (IQR 18.77, 31.7), with 41.2% of participants showing insufficiency, 30.6% showing deficiency, and 28.2% having sufficient levels. Overall, psychiatric symptoms were found in 30.0% of the patients, with anxiety occurring in 15.3%, depression in 7.1%, and sleep disorders in 21.2%. Participants with psychiatric symptoms had significantly lower blood vitamin D levels compared to those without symptoms (p < 0.05). The prevalence of psychiatric symptoms was highest among those with vitamin D deficiency (46.2%), followed by those with vitamin D insufficiency (25.7%), and it was lowest in the vitamin D sufficient group (18.8%). Conclusion: Maintaining and assessing vitamin D levels in long-term COVID patients may help prevent or reduce the severity of psychiatric symptoms. Further research is needed to evaluate the effectiveness of vitamin D supplementation in long COVID patients with low vitamin D levels, as well as to monitor and assess psychological tests continuously. | en_US |
dc.language.iso | en | en_US |
dc.publisher | School of Medicine, Mae Fah Luang University | en_US |
dc.subject | Long COVID | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Psychiatric Symptoms | en_US |
dc.subject | Vitamin D | en_US |
dc.title | Prevalence of Psychiatric Symptoms Associated with Vitamin D Level in Long COVID: Preliminary Study | en_US |
dc.type | Article | en_US |
Appears in Collections: | บทความ (Article) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2025-v05-no3-p.149-158.pdf | บทความ (Article) | 265.98 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.